Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-25 · accession 0001883850-22-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-01 | 2022-02-25+ | REGN | SING GEORGE L | Dir | S - Sale | $618.25 | -4,000 | 28.0K | -12% | -$2.47M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-28 | S | D | 1,000 | $617.00 | 26,049 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-28 | S | D | 1,000 | $614.00 | 27,049 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-25 | S | D | 2,000 | $621.00 | 28,049 | D | — | — |